Federal contract award
75F40123F19006
THE OVERALL OBJECTIVE OF THIS CALL ORDER IS TO SUPPORT THE PLANNING, IMPLEMENTATION, AND REPORTING OF ONE MIXED-METHODS EVALUATION STUDY EXAMINING THE IMPLEMENTATION, OUTCOMES, AND POTENTIAL UNINTENDED CONSEQUENCES ASSOCIATED WITH SALES RESTRICTIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | B528 — Regulatory Studies |
| Parent award / vehicle | 75F40118A10042 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $965.9K |
| Current contract value | $965.9K |
| Potential contract value / ceiling | $965.9K |
| Start date | Sep 26, 2023 |
| Current end date | Sep 25, 2025 |
| Potential end date | Sep 25, 2025 |
| Latest award activity | Apr 17, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 17, 2025 | P00002 | $0 | EOI::ENDING RADICAL AND WASTEFUL GOVERNMENT DEI PROGRAMS AND PREFERENCING (JANUARY 20, 2025)::EOI BILATERAL MODIFICATION TO DESCOPE DIVERSITY, EQUITY, AND INCLUSION REQUIREMENTS. EVALUATION OF CALIFORNIA'S POLICY RESTRICTING THE SALE OF FLAVO |
| Oct 10, 2023 | P00001 | $0 | THIS BILATERAL MODIFICATION IS BEING ISSUED TO CHANGE THE CONTRACT TYPE OF THE ORDER FROM A FIRM FIXED PRICE TO A TIME AND MATERIAL CALL ORDER |
| Sep 26, 2023 | 0 | $965.9K | THE OVERALL OBJECTIVE OF THIS CALL ORDER IS TO SUPPORT THE PLANNING, IMPLEMENTATION, AND REPORTING OF ONE MIXED-METHODS EVALUATION STUDY EXAMINING THE IMPLEMENTATION, OUTCOMES, AND POTENTIAL UNINTENDED CONSEQUENCES ASSOCIATED WITH SALES RESTRICTIONS |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.